肥厚型梗阻性心肌病化学消融术后疗效观察 |
| |
引用本文: | 刘红明,陈丽星,王钰,潘家华. 肥厚型梗阻性心肌病化学消融术后疗效观察[J]. 中国心血管病研究杂志, 2013, 11(3): 199-202 |
| |
作者姓名: | 刘红明 陈丽星 王钰 潘家华 |
| |
作者单位: | 昆明医科大学第一附属医院心内科,云南省650032 |
| |
摘 要: | 目的 探讨化学消融治疗肥厚型梗阻性心肌病(HOCM)的方法及疗效.方法 15例HOCM患者,经超声心动图及导管测压证实存在左室流出道压力阶差.选择靶间隔支注入无水乙醇消融后记录左室流出道压力阶差变化,出院时、出院后1个月及出院后3个月复查超声心动图.结果 15例中消融第一间隔支11例,消融第二间隔支2例,同时消融第一、二间隔支2例.1例术后4 h死亡,其余14例度过围术期并出院随访(其中1例术后5 d置入永久双腔起搏器).术后即刻导管测量左室流出道压差较术前明显下降[(55.90±31.08)mm Hg比(92.62±43.75)mm Hg,P<0.01],出院时与术前相比,LVOTG和二尖瓣收缩期前移(SAM)幅度较术前明显改善[(45.83±27.92)mm Hg 比(84.02±35.59)mm Hg,(2.3±1.28)mm 比(4.2±1.35)mm,P<0.01];出院后1个月、3个月超声测量LVOTG、左室流出道内径、室间隔厚度和SAM幅度较术前及出院时明显改善(P<0.01).结论化学消融是治疗HOCM的有效方法,但属于破坏性手术,需严格进行手术风险控制,防止"过犹不及".
|
关 键 词: | 心肌病 肥厚型 经皮穿刺腔内室间隔心肌消融术 |
Efficiency of percutaneous transluminal septal myocardial ablation on hypertrophic obstructive cardiomyopathy |
| |
Affiliation: | LIU Hong-ming, CHEN Li-xing, WANG Yu, et al. Department of Cardiology, the First Affiliated Hospital of Kunming Medical University, Kunming 650032, China |
| |
Abstract: | Objective To evaluate the feasibility and efficiency of percutaneous transluminal septal myocardial ablation (PTSMA) for treatment of hypertrophic obstructive cardiomyopathy (HOCM). Methods Fifteen patients with 1-10 years history of HOCM underwent the PTSMA. Left ventricular outflow tract gradient (LVOTG) were measured before and after septal branches occluded by 96%-99% alcohol. The thickness of septal myocardiurn, width of LVOT and amplitude of systolic anterior motion(SAM ) were also measured before, at the time of dis- charge and 1 month and three months after PTSMA by echocardiography. Results fourteen patients were accom- plished by sigwart method, among which, DDD pacemaker was implanted in one patient because of permanent complete heart block 5 days later. One patient died from acute myocardial infarction 4 hours after ablation. Immediate post-operation, LVOTG decreased significantly from (92.62±43.75)mm Hg to (55.90±31.08)mm Hg (P〈 0.01 ). At the time of discharge, LVOTG and amplitude of SAM improved significantly [ (45.83±27.92)mm Hg vs (84.02±35.59)mm Hg, (2.3±1.28)mm vs (4.2±1.35)mm, P〈0.01]. At 1 month and 3 months follow up, LVOTG, thickness of septal myocardium, width of LVOT and amplitude of SAM had a good direction to improvement(P〈0.01 ). Conclusion PTSMA can significantly reduce LVOTG and has a satisfactory short-term efficacy in the treatment of HOCM. Risk control must be emphasized during the ablation procedure and further careful evaluation is needed. |
| |
Keywords: | Cardiomyopathy, hypertrophic Percutaneous transluminal septal myocardial ablation |
本文献已被 维普 万方数据 等数据库收录! |
| 点击此处可从《中国心血管病研究杂志》浏览原始摘要信息 |
|
点击此处可从《中国心血管病研究杂志》下载免费的PDF全文 |
|